Norephedrane en es it fr

Norephedrane Brand names, Norephedrane Analogs

Norephedrane Brand Names Mixture

  • Adderall (amphetamine + dextroamphetamine)
  • Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)

Norephedrane Chemical_Formula

C9H13N

Norephedrane RX_link

http://www.rxlist.com/cgi/generic3/adderallxr.htm

Norephedrane fda sheet

Norephedrane msds (material safety sheet)

Norephedrane Synthesis Reference

U. S. Pat. 1,879,003, (1932)

Norephedrane Molecular Weight

135.206 g/mol

Norephedrane Melting Point

Volatizes slowly at room temperature

Norephedrane H2O Solubility

Slightly

Norephedrane State

Solid

Norephedrane LogP

1.799

Norephedrane Dosage Forms

Capsules

Norephedrane Indication

For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.

Norephedrane Pharmacology

Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.

Norephedrane Absorption

It forms easily absorbed molecules that are highly lipid soluble

Norephedrane side effects and Toxicity

LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.

Norephedrane Patient Information

Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.

Norephedrane Organisms Affected

Humans and other mammals